Strategic Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $668K | Buy |
6,025
+3,141
| +109% | +$348K | 0.06% | 129 |
|
2025
Q1 | $323K | Sell |
2,884
-7,559
| -72% | -$847K | 0.03% | 201 |
|
2024
Q4 | $965K | Sell |
10,443
-47,213
| -82% | -$4.36M | 0.1% | 117 |
|
2024
Q3 | $4.83M | Buy |
57,656
+1,880
| +3% | +$158K | 0.53% | 40 |
|
2024
Q2 | $3.83M | Sell |
55,776
-388
| -0.7% | -$26.6K | 0.47% | 40 |
|
2024
Q1 | $4.11M | Buy |
56,164
+1,714
| +3% | +$126K | 0.53% | 39 |
|
2023
Q4 | $4.41M | Sell |
54,450
-1,865
| -3% | -$151K | 0.64% | 36 |
|
2023
Q3 | $4.22M | Buy |
56,315
+3,355
| +6% | +$251K | 0.7% | 27 |
|
2023
Q2 | $4.08M | Buy |
52,960
+22,773
| +75% | +$1.76M | 0.57% | 26 |
|
2023
Q1 | $2.5M | Buy |
30,187
+4,604
| +18% | +$382K | 0.45% | 36 |
|
2022
Q4 | $2.2M | Sell |
25,583
-1,100
| -4% | -$94.4K | 0.46% | 37 |
|
2022
Q3 | $1.65M | Buy |
26,683
+1,692
| +7% | +$104K | 0.37% | 50 |
|
2022
Q2 | $1.55M | Buy |
24,991
+238
| +1% | +$14.7K | 0.31% | 55 |
|
2022
Q1 | $1.47M | Buy |
24,753
+9,160
| +59% | +$545K | 0.28% | 61 |
|
2021
Q4 | $1.13M | Buy |
+15,593
| New | +$1.13M | 0.22% | 87 |
|
2020
Q4 | – | Sell |
-4,766
| Closed | -$301K | – | 196 |
|
2020
Q3 | $301K | Buy |
4,766
+1,150
| +32% | +$72.6K | 0.1% | 140 |
|
2020
Q2 | $278K | Sell |
3,616
-2,834
| -44% | -$218K | 0.1% | 140 |
|
2020
Q1 | $482K | Buy |
6,450
+1,422
| +28% | +$106K | 0.22% | 81 |
|
2019
Q4 | $327K | Buy |
5,028
+224
| +5% | +$14.6K | 0.14% | 123 |
|
2019
Q3 | $304K | Buy |
+4,804
| New | +$304K | 0.15% | 111 |
|